Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5617479 | Journal of Vascular Surgery | 2016 | 8 Pages |
Abstract
CBT can be treated with minimal morbidity and mortality; however, the subgroup of patients with positive SDH mutations may represent a variant group of younger patients. Vascular surgeons should be aware of genetic testing to identify patients and family members who should undergo additional preoperative testing and monitoring for other paragangliomas. Concomitant lymph node dissection does not appear to add value in absence of clinic suspicion for malignancy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Victor J. MD, James M. MD, William M. MD, Richard J. MD, Thomas C. MD, Michael L. MD, Samuel R. MD, MBA,